Sanofi Cash Flow Reinvestment Rate
Sanofi cash flow reinvestment rate. Sanofi (SNW2) has a Cash Flow Reinvestment Rate of 2.41x as of September 2025, reinvesting €9.04 Billion (capex €0.00 plus investments €-9.04 Billion) from operating cash flow of €3.75 Billion. Explore SNW2 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Sanofi (2016–2024)
Cash flow reinvestment rate of Sanofi from 2016 to 2024. Historical reinvestment intensity for Sanofi across 9 annual periods. Explore capital reinvestment ratio of Sanofi to see what proportion of operating cash flow is directed to capital expenditures.
Sanofi Cash Flow Reinvestment Rate by Year (2016–2024)
Sanofi cash flow reinvestment rate by year from 2016 to 2024. Year-by-year capital reinvestment analysis for Sanofi. For the full cash flow conversion analysis, see Sanofi cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.84x | €7.60 Billion | €9.08 Billion | €3.19 Billion | ▼ -6.9% |
| 2023 | 0.90x | €9.22 Billion | €10.26 Billion | €3.02 Billion | ▲ +382.9% |
| 2022 | 0.19x | €1.96 Billion | €10.53 Billion | €1.61 Billion | ▲ +12.1% |
| 2021 | 0.17x | €1.75 Billion | €10.52 Billion | €1.48 Billion | ▼ -89.3% |
| 2020 | 1.55x | €11.49 Billion | €7.42 Billion | €1.25 Billion | ▲ +777.8% |
| 2019 | 0.18x | €1.36 Billion | €7.71 Billion | €1.32 Billion | ▼ -36.9% |
| 2018 | 0.28x | €1.55 Billion | €5.55 Billion | €1.42 Billion | ▲ +42.5% |
| 2017 | 0.20x | €1.45 Billion | €7.38 Billion | €1.39 Billion | ▼ -66.5% |
| 2016 | 0.59x | €4.59 Billion | €7.84 Billion | €2.08 Billion | — |